- Home
- NEPH vs PETS Comparison
NEPH vs PETS Comparison
Compare NEPH & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEPH
- PETS
- Stock Information
- Founded
- NEPH 1997
- PETS 1996
- Country
- NEPH United States
- PETS United States
- Employees
- NEPH N/A
- PETS N/A
- Industry
- NEPH Medical/Dental Instruments
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- NEPH Health Care
- PETS Consumer Staples
- Exchange
- NEPH Nasdaq
- PETS Nasdaq
- Market Cap
- NEPH 57.2M
- PETS 57.8M
- IPO Year
- NEPH 2004
- PETS N/A
- Fundamental
- Price
- NEPH $5.18
- PETS $2.75
- Analyst Decision
- NEPH Strong Buy
- PETS Sell
- Analyst Count
- NEPH 2
- PETS 1
- Target Price
- NEPH $5.50
- PETS $3.20
- AVG Volume (30 Days)
- NEPH 79.5K
- PETS 110.2K
- Earning Date
- NEPH 11-05-2025
- PETS 10-14-2025
- Dividend Yield
- NEPH N/A
- PETS N/A
- EPS Growth
- NEPH N/A
- PETS N/A
- EPS
- NEPH 0.12
- PETS N/A
- Revenue
- NEPH $16,684,000.00
- PETS $226,972,000.00
- Revenue This Year
- NEPH $24.38
- PETS N/A
- Revenue Next Year
- NEPH $10.16
- PETS $2.98
- P/E Ratio
- NEPH $43.88
- PETS N/A
- Revenue Growth
- NEPH 21.16
- PETS N/A
- 52 Week Low
- NEPH $1.36
- PETS $2.42
- 52 Week High
- NEPH $5.98
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- NEPH 54.89
- PETS 56.35
- Support Level
- NEPH $4.52
- PETS $2.70
- Resistance Level
- NEPH $5.38
- PETS $2.90
- Average True Range (ATR)
- NEPH 0.48
- PETS 0.13
- MACD
- NEPH -0.05
- PETS 0.05
- Stochastic Oscillator
- NEPH 45.21
- PETS 69.90
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.